Syschem India [SYSCHEM] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Syschem India Ltd.

BSE
Loading...

Sun Pharmaceutical Industries Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Syschem India Ltd. wins in 7 metrics, Sun Pharmaceutical Industries Ltd. wins in 11 metrics, with 1 ties. Sun Pharmaceutical Industries Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Syschem India Ltd. Sun Pharmaceutical Industries Ltd. Better
P/E Ratio (TTM) 34.04 36.73 Syschem India Ltd.
Price-to-Book Ratio 2.29 5.15 Syschem India Ltd.
Debt-to-Equity Ratio 0.00 6.68 Tie
PEG Ratio 0.05 3.59 Syschem India Ltd.
EV/EBITDA 15.95 23.61 Syschem India Ltd.
Profit Margin (TTM) 1.51% 19.21% Sun Pharmaceutical Industries Ltd.
Operating Margin (TTM) 3.18% 26.17% Sun Pharmaceutical Industries Ltd.
EBITDA Margin (TTM) 3.18% 26.17% Sun Pharmaceutical Industries Ltd.
Return on Equity 0.50% 15.08% Sun Pharmaceutical Industries Ltd.
Return on Assets (TTM) 0.21% 11.87% Sun Pharmaceutical Industries Ltd.
Free Cash Flow (TTM) $-318.13M $119.44B Sun Pharmaceutical Industries Ltd.
Dividend Yield N/A 0.97% N/A
1-Year Return 0.28% 7.25% Sun Pharmaceutical Industries Ltd.
Price-to-Sales Ratio (TTM) 0.45 7.05 Syschem India Ltd.
Enterprise Value $2.14B $3,783.37B Sun Pharmaceutical Industries Ltd.
EV/Revenue Ratio 0.39 6.66 Syschem India Ltd.
Gross Profit Margin (TTM) 8.92% 80.96% Sun Pharmaceutical Industries Ltd.
Revenue per Share (TTM) $125 $237 Sun Pharmaceutical Industries Ltd.
Earnings per Share (Diluted) $1.48 $45.46 Sun Pharmaceutical Industries Ltd.
Beta (Stock Volatility) -0.68 0.11 Syschem India Ltd.

Syschem India Ltd. vs Sun Pharmaceutical Industries Ltd. Stock Performance Analysis

Loading Price Chart...

SYSCHEM
SUNPHARMA

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Syschem India Ltd.0.08%-4.82%-6.12%1.56%-7.96%1.13%
Sun Pharmaceutical Industries Ltd.-0.08%-3.03%-1.92%2.17%-1.01%3.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Syschem India Ltd.0.28%14.28%475.86%791.65%228.60%193.69%
Sun Pharmaceutical Industries Ltd.7.25%79.99%166.96%144.01%669.48%2,278.32%

Performance & Financial Health Analysis: Syschem India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSYSCHEMSUNPHARMA
Market Information
Market Cap i₹2.50B₹3.88T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i39,2573,903,142
90 Day Avg. Volume i23,1403,253,866
Last Close₹47.43₹1,788.50
52 Week Range₹40.50 - ₹62.00₹1,548.00 - ₹1,916.60
% from 52W High-23.50%-6.68%
All-Time High₹149.00 (Mar 03, 2003)₹1,960.35 (Sep 30, 2024)
% from All-Time High-68.17%-8.77%
Growth Metrics
Quarterly Revenue Growth0.77%0.14%
Quarterly Earnings Growth7.29%0.16%
Financial Health
Profit Margin (TTM) i0.02%0.19%
Operating Margin (TTM) i0.03%0.26%
Return on Equity (TTM) i0.01%0.15%
Debt to Equity (MRQ) i0.006.68
Cash & Liquidity
Book Value per Share (MRQ)₹21.99₹324.46
Cash per Share (MRQ)₹1.02₹115.87
Operating Cash Flow (TTM) i₹-314,030,000₹110.84B
Levered Free Cash Flow (TTM) i₹4.60M₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A0.97%
Last 12-Month Dividend iN/A₹16.50

Valuation & Enterprise Metrics Analysis: Syschem India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSYSCHEM (Apr 24, 2026)SUNPHARMA (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i34.0436.73
Forward P/E iN/A29.48
PEG Ratio i0.053.59
Price to Sales (TTM) i0.457.05
Price to Book (MRQ) i2.295.15
Market Capitalization
Market Capitalization i₹2.50B₹3.88T
Enterprise Value i₹2.14B₹3.78T
Enterprise Value Metrics
Enterprise to Revenue i0.396.66
Enterprise to EBITDA i15.9523.61
Risk & Other Metrics
Beta i-0.680.11
Book Value per Share (MRQ) i₹21.99₹324.46

Financial Statements Comparison: Syschem India Ltd. vs Sun Pharmaceutical Industries Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricSYSCHEM (2025)SUNPHARMA (2025)
Revenue/Sales i3.86B520.41B
Cost of Goods Sold i3.15B121.98B
COGS % of Revenue i81.7%23.4%
Gross Profit i706.46M398.44B
Gross Margin i18.3%76.6%
Research & Development iN/AN/A
Operating Income (EBIT) i10.47M125.81B
Operating Margin i0.3%24.2%
EBITDA i40.29M167.25B
EBITDA Margin i1.0%32.1%
Pre-Tax Income i10.12M137.52B
Pre-Tax Income % of Revenue i0.3%26.4%
Income Tax i5.52M27.72B
Income Tax % of Revenue i0.1%5.3%
Net Income (Profit) i4.60M109.65B
Profit Margin i0.1%21.1%

Balance Sheet & Liquidity Metrics

MetricSYSCHEM (2025)SUNPHARMA (2025)
Cash & Equivalents i21.37M102.69B
Total Current Assets i1.61B526.24B
Total Current Assets % of Revenue i41.8%101.1%
Total Current Liabilities i1.24B181.94B
Total Current Liabilities % of Revenue i32.1%35.0%
Long-Term Debt i03.58B
Long-Term Debt % of Revenue i0.0%0.7%
Total Shareholders Equity i912.88M724.86B
Retained Earnings i-106.44M578.62B
Retained Earnings % of Revenue i-2.8%111.2%
Property, Plant & Equipment i19.33M100.36B

Cash Flow Statement Comparison

MetricSYSCHEM (2025)SUNPHARMA (2025)
Operating Cash Flow i-314.03M110.84B
Operating Cash Flow % of Revenue i-8.1%21.3%
Capital Expenditures i-216.88M-20.68B
Free Cash Flow i-318.13M119.44B
FCF Margin i-8.2%23.0%
Debt Repayment iN/A-43.44B
Common Stock Repurchase iN/A-29.00B

Short Interest & Institutional Ownership Analysis

MetricSYSCHEMSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i49.01M2.40B
Float Shares i15.45M1.07B
% Held by Insiders i75.43%55.62%
% Held by Institutions i0.00%28.69%
% Held by Public i24.57%15.69%

Dividend Analysis & Yield Comparison: Syschem India Ltd. vs Sun Pharmaceutical Industries Ltd.

MetricSYSCHEMSUNPHARMA
Last 12-Month Dividend iN/A₹16.50
Last 12-Month Dividend Yield iN/A0.97%
3-Year Avg Annual Dividend iN/A₹17.33
3-Year Avg Dividend Yield iN/A0.51%
3-Year Total Dividends iN/A₹52.00
Ex-Dividend DateN/AFeb 05, 2026